Artelon

Artelon, founded in 1999 and now part of Stryker, is a pioneer in regenerative medical devices for soft tissue reconstruction. Its core technology is the FLEXBAND Dynamic Matrix, a patented, biodegradable co-polymer textile that augments ligament and tendon repairs by providing immediate strength, maintaining elasticity during motion, and gradually integrating into new tissue over 4-6 years. With over 60,000 implantations worldwide, the company targets the significant clinical need for improved outcomes in ankle instability and other joint soft tissue injuries. Its integration into Stryker provides substantial commercial and R&D resources for future growth.

Patented co-polymer (polycaprolactone/polyurethane-urea) textile matrix (FLEXBAND/Dynamic Matrix) designed for strength, elasticity, and cellular integration to augment and biologically restore tendons and ligaments.

Artelon competes in the sports medicine soft tissue augmentation market against major players like Arthrex, Smith & Nephew, and ConMed, who offer biologic scaffolds, synthetic meshes, and allografts. Its key differentiation is the combination of dynamic elasticity with long-term bio-integration, a unique profile aimed at addressing the limitations of static, non-degrading synthetics and rapidly resorbable biologics.